jun-N-terminal kinase regulates thrombin-induced PAI-1 gene expression in proximal tubular epithelial cells

Kidney International

Volumn 65, Issue 6, 2004, Pages 2249-2261

  Pontrelli, Paola ^b   Ranieri, Elena ^b   Ursi, Michele ^b   Ghosh Choudhury, Goutham ^b   Gesualdo, Loreto ^b   Schena, Francesco Paolo ^b   Grandaliano, Giuseppe ^a  

^a UNIVERSITY OF BARI   (Italy)

^b NONE

Author keywords

AP 1; JNK; PAI 1; PAR 1; src; Tubulointerstitial disease

Indexed keywords

STRESS ACTIVATED PROTEIN KINASE; THROMBIN;

ARTICLE; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; EPITHELIUM CELL; GENE CONTROL; GENE SEQUENCE; HUMAN; HUMAN CELL; KIDNEY PROXIMAL TUBULE; PHOSPHORYLATION; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 2442713758     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00644.x     Document Type: Article

References (45)

1. YAMAMOTO K, LOSKUTOFF DJ: The kidney of mice with autoimmune disease acquire a hypofibrinolytic/procoagulant state that correlates with the development of glomerulonephritis and tissue microthrombosis. Am J Pathol 151:725-734, 1997
2. ENESTROM S, DRUIT H, RAMMER L: Fibrin deposition in the kidney in post-ischaemic renal damage. Br J Exp Pathol 69:387-394, 1988
3. FAULK WP, GARGIULO P, MCINTYRE JA, BANG NU: Hemostasis and fibrinolysis in renal transplantation. Semin Thromb Hemostasis 15:88-98, 1989
4. WANG Y, PRATT JR, TAM FW, et al: Upregulation of type 1 plasminogen activator inhibitor mRNA with thrombotic changes in renal grafts. Transplantation 61:684-689, 1996
5. WANG Y, PRATT JR, HARTLEY B, et al: Expression of tissue type plasminogen activator and type 1 plasminogen activator inhibitor and persistent fibrin deposition in chronic renal allograft failure. Kidney Int 52:371-377, 1997
6. WENDT T, ZHANG YM, BIERHAUS A, et al: Tissue factor expression in an animal model of hydronephrosis. Nephrol Dial Transplant 10:1820-1828, 1995
7. MANN KG, LUNDBLAD RL: Biochemistry of thrombin, in Homeostasis and Thrombosis, edited by Colman R, Hirsh J, Marder V, Salzman E, Philadelphia, Lippincott, 1987, pp 148-161
8. WILNER GD, DANITZ MP, MUDD MS, et al: Selective immobilization of α-thrombin by surface-bound fibrin. J Lab Clin Med 97:403-411, 1981
9. GRANDALIANO G, MONNO R, RANIERI E, et al: Regenerative and proinflammatory effects of thrombin on human proximal tubular cells. J Am Soc Nephrol 11:1016-1025, 2000
10. GRANDALIANO G, DI PAOLO S, MONNO R, et al: Protease activated receptor-1 and plasminogen activator inhibitor-1 expression in chronic allograft nephropathy: The role of coagulation and fibrinolysis in renal graft fibrosis. Transplantation 72:1437-1443, 2001
11. GRANDALIANO G, GESUALDO L, SCHENA FP: Thrombin: A novel renal growth factor. Exp Nephrol 7:20-25, 1999
12. DEMPSEY EC, NEWTON AC, MOCHLY-ROSEN D, et al: Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 279:L429-L438, 2000
13. GRANDALIANO G, CHOUDHURY GG, BISWAS P, ABBOUD HE: Mitogenic signalling of thrombin in mesangial cells: Role of tyrosine phosphorylation. Am J Physiol 267: F528-F536, 1994
14. WEISS RH, NUCCITELLI R: Inhibition of tyrosine phosphorylation prevents thrombin-induced mitogenesis, but not intracellular free calcium release, in vascular smooth muscle cells. J Biol Chem 267:5608-5613, 1992
15. GRANDALIANO G, VALENTE AJ, ABBOUD HE: A novel biologic effect of thrombin: Stimulation of monocyte chemotactic peptide-1 production. J Exp Med 179:1737-1741, 1994
16. VILLAMEDIANA LM, RONDEAU E, HE CJ, et al: Thrombin regulates components of the fibrinolytic system in human mesangial cells. Kidney Int 38:956-961, 1990
17. LOSKUTOFF DJ, QUIGLEY JP: PAI-1, fibrosis, and the elusive provisional fibrin matrix. J Clin Invest 106:1441-1443, 2000
18. REROLLE J-P, HERTIG A, NGUYEN G, et al: Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. Kidney Int 58:1841-1850, 2000
19. HE CJ, RONDEAU E, MEDCALF RL, et al: Thrombin increases proliferation and decreases fibrinolytic activity of kidney glomerular epithelial cells. J Cell Physiol 146:131-140, 1991
20. DESCHEEMAEKER KA, WYNS S, NELLES L, et al: Interaction of AP-1-, AP-2-, and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate response. J Biol Chem 267:15086-15091, 1992
21. KEETON MR, CURRIDEN SA, VAN ZONNEVELD AJ, LOSKUTOFF DJ: Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta. J Biol Chem 266:23048-23052, 1991
22. MINDEN A, KARIN M: Regulation and function of the JNK subgroup of MAP kinases. Biochim Biophys Acta 1333:F85-F104, 1997
23. WHITMARSH AJ, DAVIS RJ: Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74:589-607, 1996
24. SCHMITZ U, THOMMES K, BEIER I, et al: Angiotensin II-induced stimulation of p21-activated kinase and c-Jun NH2-terminal kinase is mediated by Rac1 and Nck. J Biol Chem 276:22003-22010, 2001
25. COSO OA, TERAMOTO H, SIMONDS WF, GUTKIND JS: Signaling from G protein-coupled receptors to c-Jun kinase involves beta gamma subunits of heterotrimeric G proteins acting on a Ras and Rac1-dependent pathway. J Biol Chem 271:3963-3966, 1996
26. HORVAI AE, XU L, KORZUS E, et al: Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci USA 94:1074-1079, 1997
27. RYAN MJ, JOHNSON G, KIRK J, et al: HK-2: An immortalized proximal tubule epithelial cell line from normal human kidney. Kidney Int 45:48-57, 1994
28. CHEN YR, TAN TH: Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 17:173-178, 1998
29. BENNETT BL, SASAKI DT, MURRAY BW, et al: SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98:13681-13686, 2001
30. MALCOLM KC, CHAMBARD JC, GRALL D, et al: Independent activation of endogenous p21-activated protein kinase-3 (PAK3) and JNK by thrombin in CCL39 fibroblasts. J Cell Physiol 185:235-243, 2000
31. SONG S, FREEDMAN J, MODY M, LAZARUS AH: Porcine von Willebrand factor and thrombin induce the activation of c-Jun amino-terminal kinase (JNK/SAPK) whereas only thrombin induces activation of extracellular signal-related kinase 2 (ERK2) in human platelets. Br J Haematol 109:851-856, 2000
32. MAULON L, GUERIN S, RICCI JE, et al: T-cell receptor signaling pathway exerts a negative control on thrombin-mediated increase in [Ca2+]i and p38 MAPK activation in Jurkat T cells: Implication of the tyrosine kinase p56Lck. Blood 91:4232-4241, 1998
33. MITSUI H, MARUYAMA T, KIMURA S, TAKUWA Y: Thrombin activates two stress-activated protein kinases, c-Jun N-terminal kinase and p38, in HepG2 cells. Hepatology 27:1362-1367, 1998
34. GOULD KL, WOODGETT JR, COOPER JA, et al: Protein kinase C phosphorylates pp60src at a novel site. Cell 42:849-857, 1985
35. MOYERS JS, BOUTON AH, PARSONS SJ: The sites of phosphorylation by protein kinase C and an intact SH2 domain are required for the enhanced response to beta-adrenergic agonists in cells overexpressing c-src. Mol Cell Biol 13:2391-2400, 1993
36. VONDRISKA TM, ZHANG J, SONG C, et al: Protein kinase C epsilon-Src modules direct signal transduction in nitric oxide-induced cardioprotection: Complex formation as a means for cardioprotective signaling. Circ Res 88:1306-1313, 2001
37. SONG JS, SWANN PG, SZALLASI Z, et al: Tyrosine phosphorylation-dependent and -independent associations of protein kinase C-delta with Src family kinases in the RBL-2H3 mast cell line: Regulation of Src family kinase activity by protein kinase C-delta. Oncogene 16:3357-3368, 1998
38. RODRIGUEZ-FERNANDEZ JL, ROZENGURT E: Bombesin, bradykinin, vasopressin, and phorbol esters rapidly and transiently activate Src family tyrosine kinases in Swiss 3T3 cells. Dissociation from tyrosine phosphorylation of p125 focal adhesion kinase. J Biol Chem 271:27895-27901, 1996
39. TATENO M, NISHIDA Y, ADACHI-YAMADA T: Regulation of JNK by Src during Drosophila development. Science 287:324-327, 2000
40. NAGAO M, KAZIRO Y, ITOH H: The Src family tyrosine kinase is involved in Rho-dependent activation of c-Jun N-terminal kinase by Gα12. Oncogene 18:4425-4434, 1999
41. CHEN K, VITA JA, BERK BC, KEANEY JF JR: c-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves src-dependent epidermal growth factor receptor transactivation. J Biol Chem 276:16045-16050, 2001
42. WOJTA J, HOOVER RL, DANIEL TO: Vascular origin determines plasminogen activator expression in human endothelial cells. Renal endothelial cells produce large amounts of single chain urokinase type plasminogen activator. J Biol Chem 264:2846-2852, 1989
43. EVANS CP, STAPP EC, DALL'ERA MA, JUAREZ J, YANG JC. Regulation of u-PA gene expression in human prostate cancer. Int J Cancer 94:390-395, 2001
44. DUNN SE, TORRES JV, OH JS, et al: Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase. Cancer Res 61:1367-1374, 2001
45. GUERRINI L, CASALINO L, CORTI A, BLASI F: NF-kappa B-mediated regulation of urokinase gene expression by PMA and TNF-alpha in human A549 cells. FEBS Lett 393:69-73, 1996